Clinical Trial Update: A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing trabectedin plus doxorubicin liposome vs doxorubicin liposome alone in advanced-relapsed epithelial ovarian, primary peritoneal, or fall…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Doxil/Caelyx (liposomal doxorubicin)
• Yondelis (trabectedin)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Ovarian Neoplasms, Peritoneal Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2019-02-06